The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS INC | NOTE 5.000%12/1 | 00430HAC6 | 12,342,999 | 24,685,998 | PRN | SOLE | 24,685,998 | 0 | 0 | |||
| BANDWIDTH INC | NOTE 0.500% 4/0 | 05988JAD5 | 32,167,800 | 40,250,000 | PRN | SOLE | 40,250,000 | 0 | 0 | |||
| BLUE OWL CAP CORP III | COM SHS | 69122G102 | 40,280,338 | 2,793,366 | SH | SOLE | 2,793,366 | 0 | 0 | |||
| EQUITY COMWLTH | COM SH BEN INT | 294628102 | 16,903,500 | 9,550,000 | SH | SOLE | 9,550,000 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 6,600,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 | 46333XAH1 | 13,035,400 | 14,000,000 | PRN | SOLE | 14,000,000 | 0 | 0 | |||
| ON24 INC | COM | 68339B104 | 27,392,054 | 4,240,256 | SH | SOLE | 4,240,256 | 0 | 0 | |||
| REVANCE THERAPEUTICS INC | NOTE 1.750% 2/1 | 761330AB5 | 24,030,000 | 25,000,000 | PRN | SOLE | 25,000,000 | 0 | 0 | |||
| SUMMIT HOTEL PPTYS | NOTE 1.500% 2/1 | 866082AA8 | 21,965,949 | 22,664,000 | PRN | SOLE | 22,664,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 12,829,700 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | |||